Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Teva
Cipla
Julphar
AstraZeneca
US Department of Justice
Merck
Federal Trade Commission

Generated: December 18, 2018

DrugPatentWatch Database Preview

PANCREAZE Drug Profile

« Back to Dashboard

Which patents cover Pancreaze, and when can generic versions of Pancreaze launch?

Pancreaze is a drug marketed by Vivus Inc and is included in one NDA. There are five patents protecting this drug.

This drug has thirty-seven patent family members in twenty-five countries.

The generic ingredient in PANCREAZE is pancrelipase (amylase;lipase;protease). There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pancrelipase (amylase;lipase;protease) profile page.

Summary for PANCREAZE
International Patents:37
US Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Drug Prices: Drug price information for PANCREAZE
DailyMed Link:PANCREAZE at DailyMed
Drug patent expirations by year for PANCREAZE

US Patents and Regulatory Information for PANCREAZE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vivus Inc PANCREAZE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022523-005 Mar 7, 2014 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Vivus Inc PANCREAZE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022523-002 Apr 12, 2010 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vivus Inc PANCREAZE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022523-005 Mar 7, 2014 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Vivus Inc PANCREAZE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022523-004 Apr 12, 2010 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vivus Inc PANCREAZE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022523-005 Mar 7, 2014 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Vivus Inc PANCREAZE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022523-005 Mar 7, 2014 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Vivus Inc PANCREAZE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022523-001 Apr 12, 2010 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Teva
Cipla
Julphar
AstraZeneca
US Department of Justice
Merck
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.